Mark Lanier is the founder of The Lanier Law Firm, with offices in New York, Houston, Los Angeles and Palo Alto. Lanier's reputation as one of the country's top trial lawyers is based on courtroom battles involving some of the world's largest companies. Lanier won the nation's first verdict over the controversial pain medication VIOXX, and helped clear the way for a nationwide settlement for all VIOXX users. Lanier and his team are recognized in prestigious legal journals based on their work in intellectual property and business litigation, and claims involving toxic exposures, serious personal injuries, dangerous prescription drugs, defective products, medical malpractice and maritime law.
Texas Super Lawyers 2011
Texas Super Lawyers 2010
Texas Super Lawyers 2009
Texas Super Lawyers 2008
Texas Super Lawyers 2007
Texas Super Lawyers 2006
Texas Super Lawyers 2005
Texas Super Lawyers 2004
Texas Super Lawyers 2003
Top 100 Texas Super Lawyers 2011
Top 100 Houston Texas Super Lawyers 2011
Top 100 Texas Super Lawyers 2010
Top 10 Texas Super Lawyers 2010
Top 100 Houston Texas Super Lawyers 2010
Top 100 Texas Super Lawyers 2009
Top 10 Texas Super Lawyers 2009
Top 100 Houston Area Super Lawyers 2009
Top 100 Texas Super Lawyers 2008
Top 100 Houston Area Super Lawyers 2008
Top 100 Texas Super Lawyers 2007
Top 10 Texas Super Lawyers 2007
Top 100 Houston Area Super Lawyers 2007
Top 100 Texas Super Lawyers 2006
Top 100 Houston Area Super Lawyers 2006
Top 100 Houston Area Super Lawyers 2005
Top 100 Houston Area Super Lawyers 2004
Top 100 Texas Super Lawyers 2004
Top 100 Houston Area Super Lawyers 2003
Admitted: 1985, Texas
Professional Webpage: www.lanierlawfirm.com/attorneys/w_mark_lanier.htm
Honors and Awards:
Special Licenses/Certifications:
Bar/Professional Activity:
Pro bono/Community Service:
Verdicts and Settlements:
Educational Background:

Super Lawyers is a rating service of outstanding lawyers from more than 70 practice areas who have attained a high-degree of peer recognition and professional achievement. The selection process is multi-phased and includes independent research, peer nominations and peer evaluations.